Report cover image

Global STD Tests Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 196 Pages
SKU # APRC20360219

Description

Summary

According to APO Research, the global STD Tests market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for STD Tests is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for STD Tests is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the STD Tests market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for STD Tests is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the STD Tests market include Orasure, Hologic Inc., F. Hoffmann-La Roche, DiaSorin, Danaher Corporation, Cepheid Inc., Bio-Rad Laboratories, BioMerieux and Becton Dickinson and Company, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for STD Tests, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of STD Tests, also provides the value of main regions and countries. Of the upcoming market potential for STD Tests, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the STD Tests revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global STD Tests market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global STD Tests company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
STD Tests Segment by Company

Orasure
Hologic Inc.
F. Hoffmann-La Roche
DiaSorin
Danaher Corporation
Cepheid Inc.
Bio-Rad Laboratories
BioMerieux
Becton Dickinson and Company
Alere Inc.
Affymetrix
Abbott Laboratories
STD Tests Segment by Type

HIV Testing
Hepatitis C Testing
Trichomonas’s Testing
Gonorrhoea Testing
Syphilis Testing
Chlamydia Testing
STD Tests Segment by Application

Diagnostic Centres
Hospitals
Homecare
Others
STD Tests Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global STD Tests status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the STD Tests key companies, revenue, market share, and recent developments.
3. To split the STD Tests breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions STD Tests market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify STD Tests significant trends, drivers, influence factors in global and regions.
6. To analyze STD Tests competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global STD Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of STD Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of STD Tests.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global STD Tests industry.
Chapter 3: Detailed analysis of STD Tests company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of STD Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of STD Tests in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Global STD Tests Market Size, 2020 VS 2024 VS 2031
1.3 Global STD Tests Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 STD Tests Market Dynamics
2.1 STD Tests Industry Trends
2.2 STD Tests Industry Drivers
2.3 STD Tests Industry Opportunities and Challenges
2.4 STD Tests Industry Restraints
3 STD Tests Market by Company
3.1 Global STD Tests Company Revenue Ranking in 2024
3.2 Global STD Tests Revenue by Company (2020-2025)
3.3 Global STD Tests Company Ranking (2023-2025)
3.4 Global STD Tests Company Manufacturing Base and Headquarters
3.5 Global STD Tests Company Product Type and Application
3.6 Global STD Tests Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global STD Tests Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 STD Tests Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 STD Tests Market by Type
4.1 STD Tests Type Introduction
4.1.1 HIV Testing
4.1.2 Hepatitis C Testing
4.1.3 Trichomonas’s Testing
4.1.4 Gonorrhoea Testing
4.1.5 Syphilis Testing
4.1.6 Chlamydia Testing
4.2 Global STD Tests Sales Value by Type
4.2.1 Global STD Tests Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global STD Tests Sales Value by Type (2020-2031)
4.2.3 Global STD Tests Sales Value Share by Type (2020-2031)
5 STD Tests Market by Application
5.1 STD Tests Application Introduction
5.1.1 Diagnostic Centres
5.1.2 Hospitals
5.1.3 Homecare
5.1.4 Others
5.2 Global STD Tests Sales Value by Application
5.2.1 Global STD Tests Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global STD Tests Sales Value by Application (2020-2031)
5.2.3 Global STD Tests Sales Value Share by Application (2020-2031)
6 STD Tests Regional Value Analysis
6.1 Global STD Tests Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global STD Tests Sales Value by Region (2020-2031)
6.2.1 Global STD Tests Sales Value by Region: 2020-2025
6.2.2 Global STD Tests Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America STD Tests Sales Value (2020-2031)
6.3.2 North America STD Tests Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe STD Tests Sales Value (2020-2031)
6.4.2 Europe STD Tests Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific STD Tests Sales Value (2020-2031)
6.5.2 Asia-Pacific STD Tests Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America STD Tests Sales Value (2020-2031)
6.6.2 South America STD Tests Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa STD Tests Sales Value (2020-2031)
6.7.2 Middle East & Africa STD Tests Sales Value Share by Country, 2024 VS 2031
7 STD Tests Country-level Value Analysis
7.1 Global STD Tests Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global STD Tests Sales Value by Country (2020-2031)
7.2.1 Global STD Tests Sales Value by Country (2020-2025)
7.2.2 Global STD Tests Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA STD Tests Sales Value Growth Rate (2020-2031)
7.3.2 USA STD Tests Sales Value Share by Type, 2024 VS 2031
7.3.3 USA STD Tests Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada STD Tests Sales Value Growth Rate (2020-2031)
7.4.2 Canada STD Tests Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada STD Tests Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico STD Tests Sales Value Growth Rate (2020-2031)
7.5.2 Mexico STD Tests Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico STD Tests Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany STD Tests Sales Value Growth Rate (2020-2031)
7.6.2 Germany STD Tests Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany STD Tests Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France STD Tests Sales Value Growth Rate (2020-2031)
7.7.2 France STD Tests Sales Value Share by Type, 2024 VS 2031
7.7.3 France STD Tests Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. STD Tests Sales Value Growth Rate (2020-2031)
7.8.2 U.K. STD Tests Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. STD Tests Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy STD Tests Sales Value Growth Rate (2020-2031)
7.9.2 Italy STD Tests Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy STD Tests Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain STD Tests Sales Value Growth Rate (2020-2031)
7.10.2 Spain STD Tests Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain STD Tests Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia STD Tests Sales Value Growth Rate (2020-2031)
7.11.2 Russia STD Tests Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia STD Tests Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands STD Tests Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands STD Tests Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands STD Tests Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries STD Tests Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries STD Tests Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries STD Tests Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China STD Tests Sales Value Growth Rate (2020-2031)
7.14.2 China STD Tests Sales Value Share by Type, 2024 VS 2031
7.14.3 China STD Tests Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan STD Tests Sales Value Growth Rate (2020-2031)
7.15.2 Japan STD Tests Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan STD Tests Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea STD Tests Sales Value Growth Rate (2020-2031)
7.16.2 South Korea STD Tests Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea STD Tests Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India STD Tests Sales Value Growth Rate (2020-2031)
7.17.2 India STD Tests Sales Value Share by Type, 2024 VS 2031
7.17.3 India STD Tests Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia STD Tests Sales Value Growth Rate (2020-2031)
7.18.2 Australia STD Tests Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia STD Tests Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia STD Tests Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia STD Tests Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia STD Tests Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil STD Tests Sales Value Growth Rate (2020-2031)
7.20.2 Brazil STD Tests Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil STD Tests Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina STD Tests Sales Value Growth Rate (2020-2031)
7.21.2 Argentina STD Tests Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina STD Tests Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile STD Tests Sales Value Growth Rate (2020-2031)
7.22.2 Chile STD Tests Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile STD Tests Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia STD Tests Sales Value Growth Rate (2020-2031)
7.23.2 Colombia STD Tests Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia STD Tests Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru STD Tests Sales Value Growth Rate (2020-2031)
7.24.2 Peru STD Tests Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru STD Tests Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia STD Tests Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia STD Tests Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia STD Tests Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel STD Tests Sales Value Growth Rate (2020-2031)
7.26.2 Israel STD Tests Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel STD Tests Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE STD Tests Sales Value Growth Rate (2020-2031)
7.27.2 UAE STD Tests Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE STD Tests Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey STD Tests Sales Value Growth Rate (2020-2031)
7.28.2 Turkey STD Tests Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey STD Tests Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran STD Tests Sales Value Growth Rate (2020-2031)
7.29.2 Iran STD Tests Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran STD Tests Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt STD Tests Sales Value Growth Rate (2020-2031)
7.30.2 Egypt STD Tests Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt STD Tests Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Orasure
8.1.1 Orasure Comapny Information
8.1.2 Orasure Business Overview
8.1.3 Orasure STD Tests Revenue and Gross Margin (2020-2025)
8.1.4 Orasure STD Tests Product Portfolio
8.1.5 Orasure Recent Developments
8.2 Hologic Inc.
8.2.1 Hologic Inc. Comapny Information
8.2.2 Hologic Inc. Business Overview
8.2.3 Hologic Inc. STD Tests Revenue and Gross Margin (2020-2025)
8.2.4 Hologic Inc. STD Tests Product Portfolio
8.2.5 Hologic Inc. Recent Developments
8.3 F. Hoffmann-La Roche
8.3.1 F. Hoffmann-La Roche Comapny Information
8.3.2 F. Hoffmann-La Roche Business Overview
8.3.3 F. Hoffmann-La Roche STD Tests Revenue and Gross Margin (2020-2025)
8.3.4 F. Hoffmann-La Roche STD Tests Product Portfolio
8.3.5 F. Hoffmann-La Roche Recent Developments
8.4 DiaSorin
8.4.1 DiaSorin Comapny Information
8.4.2 DiaSorin Business Overview
8.4.3 DiaSorin STD Tests Revenue and Gross Margin (2020-2025)
8.4.4 DiaSorin STD Tests Product Portfolio
8.4.5 DiaSorin Recent Developments
8.5 Danaher Corporation
8.5.1 Danaher Corporation Comapny Information
8.5.2 Danaher Corporation Business Overview
8.5.3 Danaher Corporation STD Tests Revenue and Gross Margin (2020-2025)
8.5.4 Danaher Corporation STD Tests Product Portfolio
8.5.5 Danaher Corporation Recent Developments
8.6 Cepheid Inc.
8.6.1 Cepheid Inc. Comapny Information
8.6.2 Cepheid Inc. Business Overview
8.6.3 Cepheid Inc. STD Tests Revenue and Gross Margin (2020-2025)
8.6.4 Cepheid Inc. STD Tests Product Portfolio
8.6.5 Cepheid Inc. Recent Developments
8.7 Bio-Rad Laboratories
8.7.1 Bio-Rad Laboratories Comapny Information
8.7.2 Bio-Rad Laboratories Business Overview
8.7.3 Bio-Rad Laboratories STD Tests Revenue and Gross Margin (2020-2025)
8.7.4 Bio-Rad Laboratories STD Tests Product Portfolio
8.7.5 Bio-Rad Laboratories Recent Developments
8.8 BioMerieux
8.8.1 BioMerieux Comapny Information
8.8.2 BioMerieux Business Overview
8.8.3 BioMerieux STD Tests Revenue and Gross Margin (2020-2025)
8.8.4 BioMerieux STD Tests Product Portfolio
8.8.5 BioMerieux Recent Developments
8.9 Becton Dickinson and Company
8.9.1 Becton Dickinson and Company Comapny Information
8.9.2 Becton Dickinson and Company Business Overview
8.9.3 Becton Dickinson and Company STD Tests Revenue and Gross Margin (2020-2025)
8.9.4 Becton Dickinson and Company STD Tests Product Portfolio
8.9.5 Becton Dickinson and Company Recent Developments
8.10 Alere Inc.
8.10.1 Alere Inc. Comapny Information
8.10.2 Alere Inc. Business Overview
8.10.3 Alere Inc. STD Tests Revenue and Gross Margin (2020-2025)
8.10.4 Alere Inc. STD Tests Product Portfolio
8.10.5 Alere Inc. Recent Developments
8.11 Affymetrix
8.11.1 Affymetrix Comapny Information
8.11.2 Affymetrix Business Overview
8.11.3 Affymetrix STD Tests Revenue and Gross Margin (2020-2025)
8.11.4 Affymetrix STD Tests Product Portfolio
8.11.5 Affymetrix Recent Developments
8.12 Abbott Laboratories
8.12.1 Abbott Laboratories Comapny Information
8.12.2 Abbott Laboratories Business Overview
8.12.3 Abbott Laboratories STD Tests Revenue and Gross Margin (2020-2025)
8.12.4 Abbott Laboratories STD Tests Product Portfolio
8.12.5 Abbott Laboratories Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.